五、近五年內國內外重要獎項：(附件三)

1、   2007-2012年相繼榮獲高雄醫學大學「研究傑出教師」

2、   2008年3月於亞太肝臟研究會(Asian-Pacific Association for the Study of Liver Disease)年會發表獲得會長獎

3、   2010年12月於亞太肝臟研究會(Asian-Pacific Association for the Study of Liver Disease)第7屆單一主題會議(日本千葉) 最佳海報獎

4、   2012年7月榮獲財團法人台灣肝臟學術文教基金會 第2屆 優秀論文獎

5、   2012年10月榮獲高雄醫學大學校友總會100年度優秀論文獎

6、   2012年11月榮獲財團法人高雄市立醫師公會第65屆 高杏獎

7、   2013年02月榮獲行政院國科會101年度傑出研究獎

六、近年內曾被國際研討會邀請演講之會議名稱及日期

2013

Ÿ   Treatment of chronic hepatitis C with first generation protease inhibitors in Asian population: Boceprevir-based triple therapy in Asian population. Taiwan Digestive disease Week, Taipei, Taiwan, October 5, 2013.

Ÿ   The role of peg-interferon/ribavirin in 2013 and beyond: the Asian perspective. Asia Pacific Hepatitis Summit 2013, Busan, Korea, August 2–3, 2013.

Ÿ   Sustained HCV clearance and increased HBsAg seroclearacne in patients with chronic hepatitis C and B during post-treatment followup. 3rd Asia Pacific Perspectives in Hepatitis Forum, Xi’an, China, 13 July 2013.

Ÿ    The current SOC of CHC and Overview of DAA studies. Emerging Leaders Forum, Seoul, Korea, March 29, 2013

2012

Ÿ   HBsAg and dual HBV+HCV infection. International Symposium on HBsAg Quantitation, Keelung, Taiwan, November 24, 2012.

Ÿ   Triple therapy and second generation drug. 10th Asian Pacific Association for the Study of the Liver Single Topic Conference, Ulaanbaatar, Mongolia, September 7-9, 2012.

Ÿ   The clinical impact of the recent research on hepatitis C: Asian perspective. 6th Ditan International Conference on Infectious Diseases, China National Convention Center, July 12– 15, 2012.

Ÿ   In light of new treatment strategies: comparison of APASL, AASLD and EASL guidelines. 2nd Asia Pacific Perspectives in Hepatitis Forum, Chiang Mai, Thailand, 1-2 June 2012.

Ÿ   Emerging Paradigms In HCV Management and new Direct-acting Antivirals. Cebu City, Philippines, February 25, 2012

Ÿ   Predictors of HCV treatment beyond of IL28B.22th Congress of the Asian Pacific Association for the Study of the Liver, Taipei, Taiwan, Feburary 16-19, 2012.

Ÿ   Optimizing Cure of Chronic Hepatitis C in Asia Pacific. 22th Congress of the Asian Pacific Association for the Study of the Liver, Taipei, Taiwan, Feburary 16-19, 2012.

Ÿ   Treatment of an HBV-HCV coinfected patient with Peg-IFN alfa-2a/RBV. 22th Congress of the Asian Pacific Association for the Study of the Liver, Taipei, Taiwan, Feburary 16-19, 2012.

2011

Ÿ  IL28B and genetic polymorphism in Taiwan. Asia Hepatitis Forum 2011, Jeju, Korea, December 4, 2011.

Ÿ  Management of Viral Hepatitis Patients on Treatment. Asia Pacific Hepatitis Summit 2011, Busan, Korea, August 19–20, 2011.

Ÿ  Personalized Therapy for Chronic Hepatitis C. 5th Ditan International Conference on Infectious Diseases, China National Convention Center, July 14– 17, 2011.

Ÿ  Role of DAAs in Asia Pacific region. 1st Asia Pacific Perspectives in Hepatitis Forum, Ho Chi Minh City, Vietnam, 18-19 June 2011.

2010

Ÿ   Laboratory testing for HCV infection and fibrosis. APASL HCV Guideline Meeting, Chiba, Japan, December 19, 2010.

Ÿ  Treatment response in Asian HCV: Different to the West. Asian Pacific Digestive Week, Kuala Lumpur, Malaysia, Sep 19–22, 2010.

Ÿ  Treatment of HCV: Difference between east and west. 4th Ditan International Conference on Infectious Diseases, Beijing International Convention Center, July 15– 18, 2010.

2009

Ÿ  Individualized Therapy for Chronic Hepatitis C. Asian Pacific Digestive Week, Taipei, Sep 27–30, 2009

Ÿ  Individualized Therapy in HCV infection – genotype 2 & 3 patients. Asian Pacific Digestive Week, Taipei, Sep 27–30, 2009

Ÿ  The role of HCV RNA monitoring. 19th Congress of the Asian Pacific Association for the Study of the Liver, Hong Kong, February 13-16, 2009

Ÿ  Accurate and Reliable HBV DNA Measurement Leads to Improved Patient Monitoring and Treatment Outcomes. 19th Congress of the Asian Pacific Association for the Study of the Liver, Hong Kong, February 13-16, 2009

2008

Ÿ   Individualized Therapy for Chronic Hepatitis C: Changes in Daily Practice.18th Congress of the Asian Pacific Association for the Study of the Liver, Seoul, Korea, March, 23^rd to 26^th 2008

Ÿ   Treatment of HCV with PEG-IFN/RBV in Asia.DDW Japan, Tokyo, October 1-3, 2008

Ÿ   Prevention of HCC in HCV Patients.The 4th Asian Pacific Association for the Study of the Liver Single Topic Conference on Viral Related HCC New Grand Hyatt Nusi Dual Bali, December 5-7, 2008

七、其他資料：如擔任國際重要學會理監事、國際知名學術期刊編輯、評審委員或重要民間企業公司擔任諮詢顧問等及其他有利審查之資料。

(一) 國際重要學會理監事

1	1999-至今	財團法人台灣肝臟學術文教基金會副執行長
2	2009/01-2012/01	台灣消化系醫學會第十四屆公共事務委員會委員
3	2010/01-2011/01	台灣肝臟研究學會(TASL) 秘書長
4	2011/12-2013/12	高雄市幸福港都健康城市促進會第二屆常務理事
5	2012/08-2012/12	衛生署101年度高屏區醫療區域輔導與醫療資源整合計畫管理委員會委員
6	2011/09-至今	台灣健康醫院學會理事
7	2012/01-至今	台灣消化系醫學會第十五屆雜誌編輯委員會委員、 醫療委員會委員、公共事務委員會委員、 消化系內科專科醫師訓練醫院評鑑委員會副召集委員
8	2013/10-至今	高雄市高醫校有醫師協會第二屆理事
9	2014/01-至今	衛生福利部肝癌及肝炎防治會委員
10	2014/01-至今	台灣醫學會第九屆理事會節目委員會委員

(二) 國際知名學術期刊期刊編輯，包括：

         HONORARY EDITORS-IN-CHIEF OF SCIENTIFIC JOURNAL:

World Journal of Gastroenterology, 2010-2012 (2012, IF: 2.547)

      ACADEMIC EDITOR OF SCIENTIFIC JOURNAL:

PLOS ONE, since 2012  (2012, IF: 3.730)

      EDITOR OF SCIENTIFIC JOURNAL:

Advances in Digestive Medicine, since 2013 (非SCI)

      GEUST EDITOR:

      Hepatitis Research and Treatment, 2010 (非SCI)

            Current Hepatitis Reports, 2013 (2012, IF: 3.744)

      EDITORIAL BOARD OF SCIENTIFIC JOURNAL:

ISNR Hepatology, since 2012 (非SCI)

Gastroenterology and Hepatology, since 2011  (2012, IF: 3.325)

World Journal of Gastroenterology, 2007-2009 (2012, IF: 2.547)

The Open Infectious Diseases Journal, since 2007 (非SCI)

      ADVISORY EDITORIAL BOARD OF SCIENTIFIC JOURNAL:

      The Korean Journal of Hepatology, since 2010 (非SCI)

(三) 擔任國際知名學術期刊評審委員，包括：

The Lancet, (2012, IF: 39.060)

Hepatology, (2012, IF: 12.003)

Gut, (2012, IF: 10.732)

Journal of Hepatology, (2012, IF: 9.858)

Clinical Infectious Disease, (2012, IF: 9.374)

Canadian Medical Association Journal, (2012, IF: 6.465)

Thorax, (2012, IF: 8.376)

Journal of Infectious Disease, (2012, IF: 5.848)

Liver International,  (2012, IF: 3.870)

PLoS ONE,  (2012, IF: 3.730)

Translational Research,  (2012, IF: 3.490)

Cellular & Molecular Immunology, (2012, IF: 3.419)

Journal of Gastroenterology and Hepatology,  (2012, IF: 3.325)

Antiviral Therapy, (2012, IF: 3.073)

Journal of Viral Hepatitis,  (2012, IF: 3.082)

Expert Review of Anti-infective Therapy,  (2012, IF: 3.218)

Tissue Antigen, (2012, IF: 2.753)

Hepatology International,  (2012, IF: 2.642)

World Journal of Gastroenterology, (2012, IF: 2.547)

Journal of Biomedical Science,  (2012, IF: 2.458)

Journal of Medical Virology,  (2012, IF: 2.373)

Digestive Disease and Science, (2012, IF: 2.260)

Virology Journal,  (2012, IF: 2.092)

Archives of Medical Research, (2012, IF: 2.079)

Intervirology,  (2012, IF: 1.889)

Transactions of the Royal Society of Tropical Medicine and Hygiene, (2012, IF: 1.823)

Nephrology, (2012, IF: 1.688)

International Journal of Immunogenetics, (2012, IF: 1.355)

Journal Of Formosa Medical Association, (2012, IF: 1.000)

Kaohsiung Journal of Medical Science, (2012, IF: 0.502)

Current Pharmacogenomics, (非SCI)

      The Open Infectious Disease Journal(非SCI)